June 18, 2026 · Form 4 insider transaction
Patel Sushil bought 1,191 shares of Revolution Medicines, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Includes 1,191 restricted stock units.